Press release
Emerging Trends to Drive Non-Viral Gene Delivery Technologies Market Growth at 15.2% CAGR Through 2029
Non Viral Gene Delivery Technologies
Non-Viral Gene Delivery Technologies Market Size Growth Forecast: What to Expect by 2025?
The market size of non-viral gene delivery technologies has seen a swift increase in the past few years, expanding from $3.96 billion in 2024 to $4.57 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.6%. Factors such as the broadening scope of genetic research, escalating occurrence of chronic genetic disorders, burgeoning R&D in the pharmaceutical and biotechnology sectors, rising interest in genetic and molecular biology research, and augmented funding from the government and institutions have all contributed to this historic growth.
How Will the Non-Viral Gene Delivery Technologies Market Size Evolve and Grow by 2029?
Expectations predict a significant expansion in the market size of non-viral gene delivery technologies over the upcoming years, reaching a worth of $8.06 billion in 2029 with a compound annual growth rate (CAGR) of 15.2%. Factors contributing to this forecasted growth include the heightened demand for personalized medicine, an increase in utilisation within cancer and rare disease research, the emergence and application of clustered regularly interspaced short palindromic repeats and gene editing technologies, the swift proliferation of mRNA-based therapeutics, and developments in cell therapy and tissue engineering. Trends to look out for within this period encompass advancements in lipid nanoparticles and polymer-based vectors, progression in the creation of deoxyribonucleic acid and ribonucleic acid therapeutics, incorporation of artificial intelligence and computational modeling, the next wave of lipid nanoparticles (LNPs), and progress in the field of nanotechnology.
View the full report here:
https://www.thebusinessresearchcompany.com/report/non-viral-gene-delivery-technologies-global-market-report
What Drivers Are Propelling the Growth of Non-Viral Gene Delivery Technologies Market Forward?
As we see a surge in the demand for personalized medicine, the non-viral gene delivery technologies market is poised for significant growth. Also known as precision medicine, personalized medicine is a medical model that tailors prevention, diagnosis, and treatment plans based on an individual's genetics, lifestyle, and environmental factors. The interest in personalized medicine is driven by advancements in genomic sequencing technologies, allowing for a more precise diagnosis, focused therapies, and enhanced individualized treatment outcomes. As a result, this stems the demand for non-viral gene delivery technologies, providing safer and more adjustable ways of transferring therapeutic genes, tailored to an individual's genetics, and without the associated risks of viral vectors. For instance, in February 2024, the Personalized Medicine Coalition, a non-profit based in the US, stated that the FDA had granted approval to 16 new personalized therapies designed for patients with rare diseases in 2023, compared to 6 in 2022. Hence, the surging interest in personalized medicine is stimulating the growth of the non-viral gene delivery technologies market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27367&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Non-Viral Gene Delivery Technologies Market?
Prominent enterprises in the non-viral gene delivery market are concentrating on the creation of advanced solutions like non-viral genetic medicine platforms. These advance the safety and effectiveness of gene therapies. A non-viral genetic medicine platform introduces therapeutic genes or nucleic acids into cells without the use of viruses, lessening immune reactions and concerns about safety. It also allows for accurate and regulated gene therapy delivery for a myriad of diseases. For instance, Generation Bio Co., a biotechnology firm based in the US that focuses on genetic medicines, unveiled its immune-quiet DNA (iqDNA) in October 2023. This innovative DNA is a refined version of their closed-ended DNA (ceDNA) that manages to evade innate immune detection, exhibiting levels of cytokine and tolerance on par with chemically modified mRNA in mice and non-human primates when delivered through their lipid nanoparticle (LNP) system. As a result of the outstanding tolerability of iqDNA, Generation Bio is progressing this as the main DNA cargo in all its projects, which includes their primary hemophilia A initiative.
What Are the Key Segments in the Non-Viral Gene Delivery Technologies Market?
The non-viral gene delivery technologies market covered in this report is segmented
1) By Product: Reagents And Kits, Delivery Devices, Pre-Formulated Nanoparticles
2) By Delivery: In-Vitro, In-Vivo, Ex-Vivo
3) By Technology: Electroporation, Lipid-Based Transfection, Polymer-Based Transfection, Physical Methods (Microinjection, Gene Gun), Nanoparticles
4) By Application: Gene Therapy, Deoxyribonucleic Acid (DNA) Vaccines, Ribonucleic Acid Interference (RNAi), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or Cas9 Gene Editing, Protein Expression
5) By End-Use: Biotechnology And Biopharmaceutical Companies, Research And Academic Institutes, Other End-Uses
Subsegments:
1) By Reagents And Kits: Transfection Reagents, Plasmid Deoxyribonucleic Acid (DNA) Kits, Messenger Ribonucleic Acid (RNA) Delivery Kits, Small Interfering Ribonucleic Acid (RNA) Delivery Kits, Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein Reagents, Cell-Specific Delivery Reagents
2) By Delivery Devices: Electroporation Systems, Microinjection Systems, Gene Guns Or Biolistic Delivery Devices, Ultrasound-Mediated Delivery Devices, Hydrodynamic Gene Delivery Systems
3) By Pre-Formulated Nanoparticles: Lipid-Based Nanoparticles, Polymer-Based Nanoparticles, Gold-Based Nanoparticles, Dendrimer-Based Nanoparticles, Carbon Nanotube-Based Nanoparticles, Inorganic Compound-Based Nanoparticles
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27367&type=smp
Who Are the Key Players Shaping the Non-Viral Gene Delivery Technologies Market's Competitive Landscape?
Major companies operating in the non-viral gene delivery technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Evonik Industries AG, Moderna Inc., Boehringer Ingelheim GmbH, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corp., Takara Bio Inc., GenScript Biotech Corporation, Poseida Therapeutics Inc., ElevateBio LLC, ProBio Inc., ReCode Therapeutics Inc., Altogen Biosystems Inc., Generation Bio, Indee Labs Inc.
What Geographic Markets Are Powering Growth in the Non-Viral Gene Delivery Technologies Market?
North America was the largest region in the non-viral gene delivery technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-viral gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27367
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends to Drive Non-Viral Gene Delivery Technologies Market Growth at 15.2% CAGR Through 2029 here
News-ID: 4171435 • Views: …
More Releases from The Business Research Company
Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025?
The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound…
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)…
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025?
The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound…
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research.
The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth.
The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically…
